Online Webinar conference on Epilepsy & Treatment
Theme: Impact of #COVID19 on management of #Epilepsy
Abstract Submission last date 15th May
Event Date & Time: September 21-22, 2020
Event Location: Online Webinar Event
Visit:https://t.co/1PK3AI4MEK
@epilepsyct@GBSSupport@EFCST
If you haven't yet seen it, check out me interviewing @timbuckinx - CEO of @wrepihunter & dad to a lovely son with the rare #epilepsy Ring20. Tim explains us how technologies are bettering the lives of many with epilepsy.
https://t.co/NUBkU8YB0d
#raredisease#ring20
@SBeniczky A study by Radhakrishnan et al. highlights the consequences of misinterpretation of benign #EEG variants as epileptiform. https://t.co/rqJcU3kbPs #Epilepsy#ClinicalNeuroph
Great paper out on #epilepsy and #Covid19. Authors include @epilepsia who follows some NY Syngapians and #SRF SAB member @ingridscheffer. Thx to @krispmelb for sharing.
A new paper written by a global team https://t.co/KHLm8NV75o
Congrats to Zeto, which is developing a new way to do #EEG. @epilepsyfdn gave them seed funds and they are now on the market. They just closed their series A financing to move forward! Learn more: https://t.co/uOjMxQeluE
Inspired by @alzassociation, in 2016 @EpilepsyFdn started their own #research roundtable to discuss solutions for roadblocks in getting new therapies to #clinicaltrials. Learn more: https://t.co/9DtwEpuyHL
Neurotrophic factors critical for growth & survival of neurons. Learn what researchers found about relationship between targeted, continuous delivery of glial cell line-derived neurotrophic factor (GDNF) to specific regions of brain & seizure frequency. https://t.co/B6RUVQlkio
Congrats to Cerebral Therapeutics which is developing a drug delivery system for #epilepsy. @epilepsyfdn gave them seed funds and they just raised additional funds to move forward in #clinicaltrial! https://t.co/PtdNppK9Aa
The assistant professor of psychology at @EastCarolina spoke to the challenges of overcoming #adherence issues in patients with #epilepsy, for whom it is so vital.
https://t.co/9h4zU3LmXN
Did you miss #AES2019 but want to feel like you were there? Check out this great review by @CNSdrughunter for a synopsis of everything going on in the genetic epilepsy space! Well done 👏👏👏
Cadence Neuroscience recently raised $15 million to develop a brain stimulation therapy for the treatment of epilepsy: https://t.co/lm65akq7lx. The medical device startup received a New Therapy Commercialization Grant from the Epilepsy Foundation in January 2019.
Congrats to Cadence Neuroscience for getting additional funding! In Jan 2019, @EpilepsyFdn gave seed funds to them for developing nextgen #neuro stimulation #devices for #epilepsy! Another example of our great track record for successful investments!